trial · primary record
Anifrolumab
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1072 |
| Primary completion | 2032-12-30 |
| Primary endpoint | SAEs and Non-Serious AEs |
| Registry ID | NCT07691970 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:08.251Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07691970
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Anifrolumab · compound